FR2531859A1 - Produits pharmaceutiques avec action analgesique a base d'acides gras - Google Patents
Produits pharmaceutiques avec action analgesique a base d'acides gras Download PDFInfo
- Publication number
- FR2531859A1 FR2531859A1 FR8313232A FR8313232A FR2531859A1 FR 2531859 A1 FR2531859 A1 FR 2531859A1 FR 8313232 A FR8313232 A FR 8313232A FR 8313232 A FR8313232 A FR 8313232A FR 2531859 A1 FR2531859 A1 FR 2531859A1
- Authority
- FR
- France
- Prior art keywords
- fatty acids
- esters
- analgesic
- short chain
- chain fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000002148 esters Chemical class 0.000 title claims abstract description 15
- 230000000202 analgesic effect Effects 0.000 title claims abstract description 12
- 150000004666 short chain fatty acids Chemical class 0.000 title claims abstract description 4
- 235000021391 short chain fatty acids Nutrition 0.000 title claims abstract description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 14
- 229930195729 fatty acid Natural products 0.000 claims abstract description 14
- 239000000194 fatty acid Substances 0.000 claims abstract description 14
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 12
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 claims abstract description 3
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical class CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 claims abstract 2
- 150000001656 butanoic acid esters Chemical class 0.000 claims abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 11
- 229940127557 pharmaceutical product Drugs 0.000 claims description 9
- -1 hydroxyl fatty acids Chemical class 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- WOWBFOBYOAGEEA-UHFFFAOYSA-N diafenthiuron Chemical compound CC(C)C1=C(NC(=S)NC(C)(C)C)C(C(C)C)=CC(OC=2C=CC=CC=2)=C1 WOWBFOBYOAGEEA-UHFFFAOYSA-N 0.000 claims 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 3
- 239000003995 emulsifying agent Substances 0.000 abstract description 3
- 239000000787 lecithin Substances 0.000 abstract description 3
- 235000010445 lecithin Nutrition 0.000 abstract description 3
- 229940067606 lecithin Drugs 0.000 abstract description 3
- 201000011510 cancer Diseases 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 238000002347 injection Methods 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical class CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 229940035676 analgesics Drugs 0.000 description 4
- 239000000730 antalgic agent Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 229940124641 pain reliever Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- QOPBEBWGSGFROG-UHFFFAOYSA-N 2-(1h-indol-2-yl)acetic acid Chemical class C1=CC=C2NC(CC(=O)O)=CC2=C1 QOPBEBWGSGFROG-UHFFFAOYSA-N 0.000 description 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical class OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 206010027452 Metastases to bone Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 206010038678 Respiratory depression Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229940083761 high-ceiling diuretics pyrazolone derivative Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- INAXVFBXDYWQFN-XHSDSOJGSA-N morphinan Chemical compound C1C2=CC=CC=C2[C@]23CCCC[C@H]3[C@@H]1NCC2 INAXVFBXDYWQFN-XHSDSOJGSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical class O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- DNTVKOMHCDKATN-UHFFFAOYSA-N pyrazolidine-3,5-dione Chemical class O=C1CC(=O)NN1 DNTVKOMHCDKATN-UHFFFAOYSA-N 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823229955 DE3229955A1 (de) | 1982-08-12 | 1982-08-12 | Arzneimittel mit analgetischer wirkung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2531859A1 true FR2531859A1 (fr) | 1984-02-24 |
| FR2531859B3 FR2531859B3 (OSRAM) | 1985-03-08 |
Family
ID=6170655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8313232A Granted FR2531859A1 (fr) | 1982-08-12 | 1983-08-11 | Produits pharmaceutiques avec action analgesique a base d'acides gras |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE897536A (OSRAM) |
| DE (1) | DE3229955A1 (OSRAM) |
| FR (1) | FR2531859A1 (OSRAM) |
| LU (1) | LU84952A1 (OSRAM) |
| NL (1) | NL8302830A (OSRAM) |
| SE (1) | SE8304331L (OSRAM) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005107875A3 (en) * | 2004-05-12 | 2006-03-23 | Ketocytonyx Inc | Triglycerides, fatty acids, alcohols as cns modulators |
| US7485743B2 (en) | 2004-07-20 | 2009-02-03 | Btg International Limited | Oligomeric ketone compounds |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8803141L (sv) * | 1988-09-07 | 1990-03-08 | Kabivitrum Ab | Naeringsmedel foer maenniskor och djur |
-
1982
- 1982-08-12 DE DE19823229955 patent/DE3229955A1/de not_active Withdrawn
-
1983
- 1983-08-04 LU LU84952A patent/LU84952A1/de unknown
- 1983-08-09 SE SE8304331A patent/SE8304331L/ not_active Application Discontinuation
- 1983-08-11 NL NL8302830A patent/NL8302830A/nl not_active Application Discontinuation
- 1983-08-11 FR FR8313232A patent/FR2531859A1/fr active Granted
- 1983-08-12 BE BE0/211358A patent/BE897536A/fr not_active IP Right Cessation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005107875A3 (en) * | 2004-05-12 | 2006-03-23 | Ketocytonyx Inc | Triglycerides, fatty acids, alcohols as cns modulators |
| EP2316530A1 (en) * | 2004-05-12 | 2011-05-04 | BTG International Limited | Triglycerides, fatty acids, alcohols as CNS modulators |
| US7485743B2 (en) | 2004-07-20 | 2009-02-03 | Btg International Limited | Oligomeric ketone compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| SE8304331L (sv) | 1984-02-13 |
| BE897536A (fr) | 1983-12-01 |
| DE3229955A1 (de) | 1984-02-16 |
| LU84952A1 (de) | 1983-12-28 |
| FR2531859B3 (OSRAM) | 1985-03-08 |
| NL8302830A (nl) | 1984-03-01 |
| SE8304331D0 (sv) | 1983-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5709855A (en) | Compositions of spirulina algae and omega fatty acids for treatment of inflammation and pain | |
| JPH11514999A (ja) | ビタミンｄおよびその誘導体による掻痒症治療 | |
| EP0592569A1 (en) | Composition and method for transdermal delivery of diclofenac | |
| FR2569112A1 (fr) | Systeme distributeur de medicaments par voie transcutanee | |
| EP0055635A1 (fr) | Composition pharmaceutique sous forme d'un gel contenant de l'acide acétylsalicylique | |
| CA1275249C (en) | Composition containing essential fatty acids | |
| BE1000381A4 (fr) | Preparation pharmaceutique a base d'indometacine. | |
| FR2692145A1 (fr) | Nouvelle composition à usage topique contenant de la diosmine. | |
| FR2531859A1 (fr) | Produits pharmaceutiques avec action analgesique a base d'acides gras | |
| JPS631287B2 (OSRAM) | ||
| WO2014176417A1 (en) | Topical preparation for bypassing gi tract, delivery of therapeutics, and trans-epithelial drug delivery system | |
| EP0225831A2 (fr) | Utilisation d'huiles hyperoxygénées pour la fabrication d'un médicament pour le traitement de l'herpès. | |
| KR101712747B1 (ko) | 유파틸린을 유효성분으로 포함하는 피부질환 예방 또는 치료용 조성물 | |
| EP2181709B1 (fr) | Combinaison synergique de composés analgésiques | |
| FR2686251A1 (fr) | Composition pour la cicatrisation d'une plaie. | |
| JP2860550B2 (ja) | 急性皮膚炎症治療剤 | |
| CA3036201A1 (en) | Sublingual or buccal administration of dim for treatment of skin diseases | |
| JP2788166B2 (ja) | 活性酸素消去用の組成物 | |
| CA2493074A1 (fr) | Elevation du taux d'heme oxygenase avec des derives de la rheine | |
| FR2531632A1 (fr) | Produits pharmaceutiques avec action cytostatique, a base d'esters d'acides gras | |
| FR2515962A1 (fr) | Preparations medicamenteuses contenant un derive d'acide tetraiodothyrocarboxylique notamment pour le traitement de l'hypercholesterolemie | |
| FR2843303A1 (fr) | Nouvelles compositions pharmaceutiques destinees au traitement de l'incontinence urinaire | |
| AU2019395549B2 (en) | Composition comprising dutasteride | |
| FR2635462A1 (fr) | Preparation medicamenteuse a base d'extrait d'ortie urtica kiovensis (rogiwicz), leur utilisation pour le traitement de tumeurs, et procedes de fabrication | |
| JP2006514072A (ja) | 光線療法における適用のための、並びに皮膚及び／又は関節疾患の処置のためのポルフィリン合成の物質の使用 |